
New study adds to weight loss drug makers Novo Nordisk and Eli Lilly investment case
Loading player...
Flagship Asset Management fund manager, Philip Short
New study adds to weight loss drug makers Novo Nordisk and Eli Lilly investment case
New study adds to weight loss drug makers Novo Nordisk and Eli Lilly investment case